H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the H-ras-induced invasive phenotype

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 176-181

  Moon, Aree ^a   Kim, Mi Sung ^a   Kim, Tae Gyun ^b   Kim, Seung Hee ^b   Kim, Harold E ^c   Chen, Yong Q ^c   Kim, Hyeong Reh Choi ^c  

^a Duksung Women's University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; ISOPROTEIN; MESSENGER RNA; RAS PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; ONCOGENE H RAS; ONCOGENE N RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0034650586     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<176::AID-IJC5>3.0.CO;2-E     Document Type: Article

References (21)

1. ALBINI, A., MELCHIORI, A., SANTI, L., LIOTTA, L.A., BROWN, P.D. and STETLER-STEVENSON, W.G., Tumor cell invasion inhibited by TIMP-2. J. nat. Cancer Inst., 83, 775-779 (1991).
2. BARBACID, M., ras genes. Ann. Rev. Biochem., 56, 779-827 (1987).
3. BASOLO, F., ELLIOTT, J., TAIT, L., CHEN, X.Q., MALONEY, T., RUSSO, I.H., PAULEY, R., MOMIKI, S., CAAMANO, J., KLEIN-SZANTO, A.J.P., KOSZALKA, M. and RUSSO, J., Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol. Carcinogenesis, 4, 25-35 (1991).
4. BERNHARD, E.J., GRUBER, S.B. and MUSCHEL, R.J., Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. nat. Acad. Sci. (Wash.), 91, 4293-4297 (1994).
5. BOGUSKI, M.S. and MCCORMICK, F., Proteins regulating Ras and its relatives. Nature (Lond.), 663, 643-654 (1993).
6. CARBONE, A., GUSELLA, G.L., RADZIOCH, D. and VARESIO, L., Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene, 6, 731-735 (1991).
7. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
8. CLAIR, T., MILLER, W. and CHO-CHUNG, Y., Prognostic significance of the expression of the ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res., 49, 5290-5293 (1987).
9. CLARK, G.J. and DER, C.J., Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat., 35, 133-144 (1995).
10. DELONG, R.K. and MILLER, P.S., Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates. Antisense Nucleic Acid Drug Dev., 6, 273-280 (1996).
11. GIUNCIUGLIO, D., CULTY, M., FASSINA, G., MASIELLO, L., MELCHIORI, A., PAGLIALUNGA, G., ARAND, V.G., CIARDIELLO, F., BASOLO, F., THOMPSON, E.W. and ALBINI, A., Invasive phenotype of MCFIOA cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int. J. Cancer, 63, 815-822 (1995)
12. HOWARD, E.W., BULLEN, E.C. and BANDA, M.J., Preferential inhibition of 72-and 92-kDa gelatinase by tissue inhibitor of metalloproteinases-2. J. biol. Chem., 266, 13070-13075 (1991).
13. LIOTTA, L.A., STEEG, P.S. and STETLER-STEVENSON, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
14. MAHER, J., BAKER, D.A., MANNING, M., DIBB, N.J. and ROBERTS, I.A.G., Evidence for cell-specific differences in transformation by N-, H- and K-ras. Oncogene, 11, 1639-1647 (1995).
15. OLDHAM, S.M., CLARK, G.J., GANGAROSA, L.M., COFFEY, R.J. and DER, C.J., Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. nat. Acad. Sci. (Wash.), 93, 6924-6928 (1996).
16. SATO, H., TAKINO, T., KINOSHITA, T., IMAI, K., OKADA, Y., STETLER-STEVENSON, W.G. and SEIKI, M., Cell-surface binding and activation of gelatinase A induced by expression of membrane-type-1 matrix mealloproteinase (MT1-MMP). FEBS Lett., 385, 238-240 (1996).
17. SOULE, H., MALONEY, T.M., WOLMAN S.R., PETERSON, W.D., BRENZ, R., MCGRATH, C.M., RUSSO, J., PAULEY, R.J., JONES, R.F. and BROOKS, S.C., Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50, 6075-6086 (1990).
18. STETLER-STEVENSON, W.G., Type-IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9, 289-303 (1990).
19. TRYGGVASON, K., Type-IV collagenase in invasive tumors. Breast Cancer Res. Treat., 24, 209-218 (1993).
20. URA, H., BONFIL, R.D., REICH, R., REDDEL, R., PFEIFER, A., HARRIS, C.C. and KLEIN-SZANTO, A.J.P., Expression of type IV collagenases and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49, 4615-4621 (1989).
21. WATSON, D.M., ELTON, R.A., JACK, W.J., DIXON, J.M., CHETTY, U. and MILLER, W.R., The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res. Treat., 17, 161-169 (1991).